Fascia Iliaca Compartment Block for Pain Management in Hip Fracture Patients

• Status: Recruiting
• Trial end date: 2021-10-14
• Target enrollment: 0
• Participant gender: All

Summary

BLOCKPAIN is a randomized controlled study, 80 participants. The participants will be hip fracture patients in Emergency Medicine Department in Clinical Hospital "Sveti Duh", Zagreb, Croatia. Upon patient arrival inclusion and exclusion criteria will be established. After signing the informed consent form participant will be randomized in one of two study groups. One study group is fascia iliaca compartment block (FICB), the other is placebo. All participants will be given paracetamol 1 gram IV as standard care. If needed, rescue analgesic will be tramadol 100 mg in 100 ml saline IV. The time frame is 24 hours after the FICB or placebo procedure.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: General Hospital Sveti Duh
• Treatments: Acetaminophen; Analgesics; Levobupivacaine; Tramadol

Criteria

Inclusion Criteria:

• hip fracture after minor trauma/simple falls, confirmed by imaging technique (X-ray or CT scan or MRI)

• signed informed consent form (after a verbal explanation and written information sheet)

Exclusion Criteria:

• pathological fracture

• head injury

• body mass bellow 50 kg

• cognitive impairment (Abbreviated Mental Test Score less then 6 points)

• oral anticoagulant drugs

• prior drug allergy (paracetamol, tramadol, local anesthetics)

• prior peripheral artery bypass surgery (on the same side as hip fracture)

• skin or soft tissue infection in the groin area (on the same side as hip fracture)

• simultaneously bilateral hip fracture

• opioid analgesics prior to hospital arrival